Kelly‐Anne Phillips

22.3k total citations · 2 hit papers
158 papers, 5.2k citations indexed

About

Kelly‐Anne Phillips is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Kelly‐Anne Phillips has authored 158 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Genetics, 58 papers in Oncology and 36 papers in Cancer Research. Recurrent topics in Kelly‐Anne Phillips's work include BRCA gene mutations in cancer (97 papers), Global Cancer Incidence and Screening (34 papers) and Cancer Risks and Factors (29 papers). Kelly‐Anne Phillips is often cited by papers focused on BRCA gene mutations in cancer (97 papers), Global Cancer Incidence and Screening (34 papers) and Cancer Risks and Factors (29 papers). Kelly‐Anne Phillips collaborates with scholars based in Australia, United States and United Kingdom. Kelly‐Anne Phillips's co-authors include Jack Cuzick, Kara L. Britt, John L. Hopper, Michael Friedländer, Roger L. Milne, Graham G. Giles, Ian F. Tannock, Mohamed Abdolell, Terry Bunston and Christine B. Brezden and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Nature reviews. Cancer.

In The Last Decade

Kelly‐Anne Phillips

149 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Key steps for effective breast cancer prevention

2020 546 citations Jack Cuzick, Kelly‐Anne Phillips et al. profile →
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline

2022 98 citations Cristiana Sessa, Judith Balmañà et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kelly‐Anne Phillips Australia	38	2.3k	1.8k	1.2k	1.1k	810	158	5.2k
Kathleen M. Egan United States	49	2.8k 1.2×	1.1k 0.6×	1.0k 0.9×	1.1k 1.1×	609 0.8×	159	7.8k
Kathryn J. Ruddy United States	44	4.1k 1.8×	1.3k 0.7×	1.3k 1.1×	1.6k 1.5×	1.7k 2.1×	324	8.7k
Michael S. Simon United States	49	3.8k 1.7×	2.0k 1.1×	574 0.5×	1.9k 1.8×	1.6k 1.9×	261	7.7k
Anastasia Iliadou Sweden	33	1.1k 0.5×	1.3k 0.7×	906 0.8×	695 0.7×	720 0.9×	85	6.3k
Virginia F. Borges United States	48	4.8k 2.1×	795 0.4×	1.4k 1.2×	1.8k 1.7×	538 0.7×	227	7.2k
Marion Kiechle Germany	43	2.3k 1.0×	1.2k 0.7×	666 0.6×	1.9k 1.8×	336 0.4×	311	6.2k
Saundra S. Buys United States	36	2.1k 0.9×	1.8k 1.0×	563 0.5×	1.4k 1.3×	579 0.7×	137	6.1k
Lucia Del Mastro Italy	48	5.3k 2.4×	1.6k 0.9×	1.7k 1.5×	2.5k 2.3×	1.8k 2.2×	332	8.7k
Joellen M. Schildkraut United States	51	1.7k 0.8×	2.2k 1.3×	623 0.5×	1.2k 1.1×	946 1.2×	219	8.7k
Diana Bull United Kingdom	32	2.6k 1.1×	1.4k 0.8×	389 0.3×	711 0.7×	774 1.0×	49	5.6k

Countries citing papers authored by Kelly‐Anne Phillips

Since Specialization

Citations

This map shows the geographic impact of Kelly‐Anne Phillips's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly‐Anne Phillips with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly‐Anne Phillips more than expected).

Fields of papers citing papers by Kelly‐Anne Phillips

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly‐Anne Phillips. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly‐Anne Phillips. The network helps show where Kelly‐Anne Phillips may publish in the future.

Co-authorship network of co-authors of Kelly‐Anne Phillips

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly‐Anne Phillips. A scholar is included among the top collaborators of Kelly‐Anne Phillips based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly‐Anne Phillips. Kelly‐Anne Phillips is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stormon, Nicole, et al.. (2025). Dental Service Utilisation Among First Nations’ People in Southeast Queensland. Health & Social Care in the Community. 2025(1). 1 indexed citations

Lambertini, Matteo, Eva Blondeaux, Elisa Agostinetto, et al.. (2024). Clinical behavior of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing: Results from an international cohort study.. Journal of Clinical Oncology. 42(16_suppl). 10503–10503. 1 indexed citations

Mooij, Thea M., Anouk Pijpe, Gabe S. Sonke, et al.. (2022). Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits. JNCI Journal of the National Cancer Institute. 114(4). 540–552. 7 indexed citations

Tutt, Andrew, John J. Garber, R.D. Gelber, et al.. (2022). VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer. Annals of Oncology. 33(5). 566–568. 26 indexed citations

Sessa, Cristiana, Judith Balmañà, Sharon L. Bober, et al.. (2022). Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Annals of Oncology. 34(1). 33–47. 98 indexed citations breakdown →

Milne, Roger L., et al.. (2021). Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence. Cancer Prevention Research. 14(11). 983–994. 10 indexed citations

Cui, Wanyuan, Prudence A. Francis, Sherene Loi, et al.. (2021). Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation. JNCI Journal of the National Cancer Institute. 113(12). 1770–1778. 17 indexed citations

Mazza, Danielle, Martha Hickey, Louise Keogh, et al.. (2020). Motivators of Inappropriate Ovarian Cancer Screening: A Survey of Women and Their Clinicians. JNCI Cancer Spectrum. 5(1). 3 indexed citations

Saunders, Christobel, Louise Keogh, Danielle Mazza, et al.. (2020). Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians. Cancer Prevention Research. 14(1). 131–144. 7 indexed citations

10.

Collins, Ian, Mathias Bressel, Phyllis Butow, et al.. (2018). The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing. JMIR Formative Research. 2(2). e24–e24. 13 indexed citations

11.

Phillips, Kelly‐Anne, et al.. (2017). Genetic testing in women with breast cancer: implications for treatment. Expert Review of Anticancer Therapy. 17(11). 991–1002. 9 indexed citations

12.

Phillips, Kelly‐Anne, Ian Collins, Roger L. Milne, et al.. (2016). Anti-Müllerian Hormone Serum Concentrations of Women With Germline BRCA1 or BRCA2 Mutations. Obstetrical & Gynecological Survey. 71(8). 474–475. 8 indexed citations

13.

Collins, Ian, Adrian Bickerstaffe, Louise Keogh, et al.. (2016). iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management. Breast Cancer Research and Treatment. 156(1). 171–182. 26 indexed citations

14.

Lee, Yeh Chen, Roger L. Milne, Charmaine Smith, et al.. (2016). Risk of uterine cancer in BRCA1 and BRCA2 mutation carriers.. Journal of Clinical Oncology. 34(15_suppl). 1529–1529. 1 indexed citations

15.

MacInnis, Robert J., Adrian Bickerstaffe, Carmel Apicella, et al.. (2013). Prospective validation of the breast cancer risk prediction model BOADICEA and a batch-mode version BOADICEACentre. British Journal of Cancer. 109(5). 1296–1301. 36 indexed citations

16.

Peate, Michelle, Bettina Meiser, Benjamin C. Cheah, et al.. (2012). Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. British Journal of Cancer. 106(6). 1053–1061. 132 indexed citations

17.

Mitchell, Gillian, Sandra Johnson, Lisa Devereux, et al.. (2010). Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 19(1). 265–274. 22 indexed citations

18.

Phillips, Kelly‐Anne, et al.. (2005). The integrated, multidisciplinary clinic: A new model for the ongoing management of women at high genetic risk for breast and ovarian cancer. Cancer Forum. 29(2). 107. 8 indexed citations

19.

Phillips, Kelly‐Anne, et al.. (1998). Factors associated with women's adherence to mammography screening guidelines.. PubMed. 33(1). 29–53. 149 indexed citations

20.

Phillips, Kelly‐Anne, et al.. (1996). High-dose gamma-globulin responsive haemolysis due to cytomegalovirus in an immunocompetent adult.. PubMed. 95(2). 433–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact